← FDA Drug Approvals (Drugs@FDA)

GLYCOPHOS

NDA · New Drug Application · Sponsor: FRESENIUS KABI USA · Approved 2026-07-29

Drug application

FDA Application #

NDA220381

Application type

New Drug Application

Brand name

GLYCOPHOS

Generic name

Sodium Glycerophosphate

Active ingredients

SODIUM GLYCEROPHOSPHATE

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

FRESENIUS KABI USA

First approval

2026-07-29

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown